Guocan Wang, Ph.D.

Affiliations: 
2011 Weill Cornell Medical College, New York, NY, United States 
Area:
Oncology, Molecular Biology, Cell Biology
Google:
"Guocan Wang"

Parents

Sign in to add mentor
Pier P. Pandolfi grad student 2011 Weill Cornell Medical College
 (The role of Lrf/Pokemon in cancer pathogenesis and development.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee YC, Lin SC, Yu G, et al. (2021) Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition. Oncogene
Zhu M, Peng R, Liang X, et al. (2021) P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis. Oncogene
Yu G, Shen P, Lee YC, et al. (2021) Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4. Iscience. 24: 102388
Lunardi A, Ala U, Epping MT, et al. (2020) Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genetics
Zhao D, Cai L, Lu X, et al. (2020) Chromatin Regulator, CHD1, Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer. Cancer Discovery
Corn PG, Zhang M, Nogueras-Gonzalez GM, et al. (2020) A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Liao W, Overman MJ, Boutin A, et al. (2020) Abstract IA27: Context-dependent role of KRAS in GI malignancies Molecular Cancer Research. 18
Wang G, Lu X, Chakravarti D, et al. (2020) Abstract IA24: YAP in cancer and inflammation Molecular Cancer Research. 18
Su W, Han HH, Wang Y, et al. (2019) The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression. Cancer Cell
Liao W, Overman MJ, Boutin AT, et al. (2019) KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. Cancer Cell
See more...